Work

Supplementary Table S3 from A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment

Year: 2023

Type: supplementary-materials

DOI: 10.1158/0008-5472.22430376

Authors: Feng Xu, Man Tong, Cindy S.W. Tong, Becky K.C. Chan, Hoi Yee Chu, Tin Lok Wong, John H.C. Fong, Maggie S.H. Cheung, Kylie Hin-Man Mak, Lakhansing Pardeshi, Yuanhua Huang, Koon Ho Wong, Gigi C.G. Choi, Stephanie Ma, Alan S.L. Wong

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362391229

Cites:

Cited by:

Related to: 10